Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1093599

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1093599

Asia Pacific Wearable Injectors Market Size, Share & Industry Trends Analysis Report By Therapy (Diabetes, Cardiovascular disease, Immuno-oncology), By End User, By Type, By Technology, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 106 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Asia Pacific Wearable Injectors Market would witness market growth of 9.8% CAGR during the forecast period (2022-2028).

Wearable injectors that may work in combination with other devices, as well as technologies, are easy to popularize in the presence of numerous new technologies that have been introduced to the forefront of the healthcare sector. The delivery system is a vital part of the treatment process because it ensures that medication doses are administered on time. Given these facts, it is reasonable to anticipate that the wearable injectors market would continue to grow in the coming years.

Wearable injection systems are the natural development of chronic disorder management in a world that needs everything to happen immediately. The concept of patient-centricity and greater attention to human factors in drug delivery design has fueled the development of these devices. The growing use of biologics in drug research has aided the development of delivery systems capable of handling high-viscosity solutions. As a result of these circumstances, wearable injection systems have emerged, offering a whole new set of design and testing issues.

Device manufacturers face a unique design problem with this component. Adhesives are not a compound present in many traditional drug-delivery devices, necessitating the development of new skills and knowledge. The adhesive characteristics of the product must be optimized for patient comfort during usage and removal, and the adhesive patch must be developed in such a way that proper orientation, as well as skin contact, are maintained throughout the delivery process.

Infectious illness threats can be swiftly prevented, detected, and responded to in countries with robust and resilient public health systems before they become pandemic. According to the Centers for Disease Control and Prevention, China's ecology provides a risk for developing, re-emerging, and novel illnesses that could threaten China, along with other regional countries, with a population of over 1.4 billion people and 50% of the world's livestock. The world's expanding network of air travel routes greatly raises the chance of illnesses spreading quickly, including infections that could lead to pandemics like COVID-19, causing worldwide trade disruption, illness, or death. The CDC encourages China to build effective procedures for addressing disease outbreaks at their cause. CDC along with the China Center for Disease Control, also known as China CDC, have partnered in supporting global public health activities as China's domestic public health capability has increased. In addition, the CDC works with China's CDC to promote the one health approach, which recognizes that human health is linked to animal and environmental health. This strategy tries to lessen the burden of brucellosis, rabies, and other zoonotic illnesses on humans.

The China market dominated the Asia Pacific Wearable Injectors Market by Country 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $981.9 Million by 2028. The Japan market is poised to grow at a CAGR of 9.1% during (2022 - 2028). Additionally, The India market would witness a CAGR of 10.5% during (2022 - 2028).

Based on Therapy, the market is segmented into Diabetes, Cardiovascular disease, Immuno-oncology, and Others. Based on End User, the market is segmented into Hospitals & Clinics and Home healthcare setting. Based on Type, the market is segmented into On-body Injector and Off-body Injector. Based on Technology, the market is segmented into Spring Based, Motor Based, Rotary pump, Expanding battery, and other. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Insulet Corporation, United Therapeutics Corporation, ATS Automation Tooling Systems, Inc., Ypsomed AG, Amgen, Inc., West Pharmaceutical Services, Inc., Zealand Pharma A/S (Valeritas, Inc.), Medtronic PLC, CeQur SA, and Subcuject ApS.

Scope of the Study

Market Segments covered in the Report:

By Therapy

  • Diabetes
  • Cardiovascular disease
  • Immuno-oncology
  • Others

By End User

  • Hospitals & Clinics
  • Home healthcare setting

By Type

  • On-body Injector
  • Off-body Injector

By Technology

  • Spring Based
  • Motor Based
  • Rotary pump
  • Expanding battery
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • Insulet Corporation
  • United Therapeutics Corporation
  • ATS Automation Tooling Systems, Inc.
  • Ypsomed AG
  • Amgen, Inc.
  • West Pharmaceutical Services, Inc.
  • Zealand Pharma A/S (Valeritas, Inc.)
  • Medtronic PLC
  • CeQur SA
  • Subcuject ApS

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Wearable Injectors Market, by Therapy
    • 1.4.2 Asia Pacific Wearable Injectors Market, by End User
    • 1.4.3 Asia Pacific Wearable Injectors Market, by Type
    • 1.4.4 Asia Pacific Wearable Injectors Market, by Technology
    • 1.4.5 Asia Pacific Wearable Injectors Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
    • 3.2.4 Approvals and Trials
    • 3.2.5 Business Expansions
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018,Apr - 2022, Apr) Leading Players

Chapter 4. Asia Pacific Wearable Injectors Market by Therapy

  • 4.1 Asia Pacific Diabetes Market by Country
  • 4.2 Asia Pacific Cardiovascular disease Market by Country
  • 4.3 Asia Pacific Immuno-oncology Market by Country
  • 4.4 Asia Pacific Others Market by Country

Chapter 5. Asia Pacific Wearable Injectors Market by End User

  • 5.1 Asia Pacific Hospitals & Clinics Market by Country
  • 5.2 Asia Pacific Home healthcare setting Market by Country

Chapter 6. Asia Pacific Wearable Injectors Market by Type

  • 6.1 Asia Pacific On-body Injector Market by Country
  • 6.2 Asia Pacific Off-body Injector Market by Country

Chapter 7. Asia Pacific Wearable Injectors Market by Technology

  • 7.1 Asia Pacific Spring Based Market by Country
  • 7.2 Asia Pacific Motor Based Market by Country
  • 7.3 Asia Pacific Rotary pump Market by Country
  • 7.4 Asia Pacific Expanding battery Market by Country
  • 7.5 Asia Pacific Others Market by Country

Chapter 8. Asia Pacific Wearable Injectors Market by Country

  • 8.1 China Wearable Injectors Market
    • 8.1.1 China Wearable Injectors Market by Therapy
    • 8.1.2 China Wearable Injectors Market by End User
    • 8.1.3 China Wearable Injectors Market by Type
    • 8.1.4 China Wearable Injectors Market by Technology
  • 8.2 Japan Wearable Injectors Market
    • 8.2.1 Japan Wearable Injectors Market by Therapy
    • 8.2.2 Japan Wearable Injectors Market by End User
    • 8.2.3 Japan Wearable Injectors Market by Type
    • 8.2.4 Japan Wearable Injectors Market by Technology
  • 8.3 India Wearable Injectors Market
    • 8.3.1 India Wearable Injectors Market by Therapy
    • 8.3.2 India Wearable Injectors Market by End User
    • 8.3.3 India Wearable Injectors Market by Type
    • 8.3.4 India Wearable Injectors Market by Technology
  • 8.4 South Korea Wearable Injectors Market
    • 8.4.1 South Korea Wearable Injectors Market by Therapy
    • 8.4.2 South Korea Wearable Injectors Market by End User
    • 8.4.3 South Korea Wearable Injectors Market by Type
    • 8.4.4 South Korea Wearable Injectors Market by Technology
  • 8.5 Singapore Wearable Injectors Market
    • 8.5.1 Singapore Wearable Injectors Market by Therapy
    • 8.5.2 Singapore Wearable Injectors Market by End User
    • 8.5.3 Singapore Wearable Injectors Market by Type
    • 8.5.4 Singapore Wearable Injectors Market by Technology
  • 8.6 Malaysia Wearable Injectors Market
    • 8.6.1 Malaysia Wearable Injectors Market by Therapy
    • 8.6.2 Malaysia Wearable Injectors Market by End User
    • 8.6.3 Malaysia Wearable Injectors Market by Type
    • 8.6.4 Malaysia Wearable Injectors Market by Technology
  • 8.7 Rest of Asia Pacific Wearable Injectors Market
    • 8.7.1 Rest of Asia Pacific Wearable Injectors Market by Therapy
    • 8.7.2 Rest of Asia Pacific Wearable Injectors Market by End User
    • 8.7.3 Rest of Asia Pacific Wearable Injectors Market by Type
    • 8.7.4 Rest of Asia Pacific Wearable Injectors Market by Technology

Chapter 9. Company Profiles

  • 9.1 Insulet Corporation
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Regional Analysis
    • 9.1.4 Research & Development Expenses
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Partnerships, Collaborations, and Agreements:
      • 9.1.5.2 Approvals anf Trials:
  • 9.2 United Therapeutics Corporation
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Regional Analysis
    • 9.2.4 Research & Development Expenses
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Product Launches and Product Expansions:
      • 9.2.5.2 Acquisition and Mergers:
  • 9.3 ATS Automation Tooling Systems, Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Regional Analysis
  • 9.4 Ypsomed AG
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Recent Strategies and Developments:
      • 9.4.4.1 Partnerships, Collaborations, and Agreements:
      • 9.4.4.2 Business Expansions:
  • 9.5 Amgen, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Regional Analysis
    • 9.5.5 Recent Strategies and Developments:
      • 9.5.5.1 Acquisitions and Mergers:
  • 9.6 West Pharmaceutical Services, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Segmental and Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent Strategies and Developments:
      • 9.6.5.1 Partnerships, Collaborations and Agreements:
      • 9.6.5.2 Product Launches and Product Expansions:
  • 9.7 Zealand Pharma A/S (Valeritas, Inc.)
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Research & Development Expenses
    • 9.7.4 Recent strategies and developments:
      • 9.7.4.1 Partnerships, Collaborations and Agreements:
  • 9.8 Medtronic PLC
    • 9.8.1 Company overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expenses
    • 9.8.5 Recent strategies and developments:
      • 9.8.5.1 Product Launches and Product Expansions:
      • 9.8.5.2 Acquisition and Mergers:
  • 9.9 CeQur SA
    • 9.9.1 Company Overview
    • 9.9.2 Recent strategies and developments:
      • 9.9.2.1 Acquisition and Mergers:
  • 9.10. Subcuject ApS
    • 9.10.1 Company Overview
    • 9.10.2 Recent strategies and developments:
      • 9.10.2.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

  • TABLE 1 Asia Pacific Wearable Injectors Market, 2018 - 2021, USD Million
  • TABLE 2 Asia Pacific Wearable Injectors Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Wearable Injectors Market
  • TABLE 4 Product Launches And Product Expansions- Wearable Injectors Market
  • TABLE 5 Acquisition and Mergers- Wearable Injectors Market
  • TABLE 6 Approvals and Trials - Wearable Injectors Market
  • TABLE 7 Business Expansions- Wearable Injectors Market
  • TABLE 8 Asia Pacific Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
  • TABLE 9 Asia Pacific Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
  • TABLE 10 Asia Pacific Diabetes Market by Country, 2018 - 2021, USD Million
  • TABLE 11 Asia Pacific Diabetes Market by Country, 2022 - 2028, USD Million
  • TABLE 12 Asia Pacific Cardiovascular disease Market by Country, 2018 - 2021, USD Million
  • TABLE 13 Asia Pacific Cardiovascular disease Market by Country, 2022 - 2028, USD Million
  • TABLE 14 Asia Pacific Immuno-oncology Market by Country, 2018 - 2021, USD Million
  • TABLE 15 Asia Pacific Immuno-oncology Market by Country, 2022 - 2028, USD Million
  • TABLE 16 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 17 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 18 Asia Pacific Wearable Injectors Market by End User, 2018 - 2021, USD Million
  • TABLE 19 Asia Pacific Wearable Injectors Market by End User, 2022 - 2028, USD Million
  • TABLE 20 Asia Pacific Hospitals & Clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 21 Asia Pacific Hospitals & Clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 22 Asia Pacific Home healthcare setting Market by Country, 2018 - 2021, USD Million
  • TABLE 23 Asia Pacific Home healthcare setting Market by Country, 2022 - 2028, USD Million
  • TABLE 24 Asia Pacific Wearable Injectors Market by Type, 2018 - 2021, USD Million
  • TABLE 25 Asia Pacific Wearable Injectors Market by Type, 2022 - 2028, USD Million
  • TABLE 26 Asia Pacific On-body Injector Market by Country, 2018 - 2021, USD Million
  • TABLE 27 Asia Pacific On-body Injector Market by Country, 2022 - 2028, USD Million
  • TABLE 28 Asia Pacific Off-body Injector Market by Country, 2018 - 2021, USD Million
  • TABLE 29 Asia Pacific Off-body Injector Market by Country, 2022 - 2028, USD Million
  • TABLE 30 Asia Pacific Wearable Injectors Market by Technology, 2018 - 2021, USD Million
  • TABLE 31 Asia Pacific Wearable Injectors Market by Technology, 2022 - 2028, USD Million
  • TABLE 32 Asia Pacific Spring Based Market by Country, 2018 - 2021, USD Million
  • TABLE 33 Asia Pacific Spring Based Market by Country, 2022 - 2028, USD Million
  • TABLE 34 Asia Pacific Motor Based Market by Country, 2018 - 2021, USD Million
  • TABLE 35 Asia Pacific Motor Based Market by Country, 2022 - 2028, USD Million
  • TABLE 36 Asia Pacific Rotary pump Market by Country, 2018 - 2021, USD Million
  • TABLE 37 Asia Pacific Rotary pump Market by Country, 2022 - 2028, USD Million
  • TABLE 38 Asia Pacific Expanding battery Market by Country, 2018 - 2021, USD Million
  • TABLE 39 Asia Pacific Expanding battery Market by Country, 2022 - 2028, USD Million
  • TABLE 40 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 41 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 42 Asia Pacific Wearable Injectors Market by Country, 2018 - 2021, USD Million
  • TABLE 43 Asia Pacific Wearable Injectors Market by Country, 2022 - 2028, USD Million
  • TABLE 44 China Wearable Injectors Market, 2018 - 2021, USD Million
  • TABLE 45 China Wearable Injectors Market, 2022 - 2028, USD Million
  • TABLE 46 China Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
  • TABLE 47 China Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
  • TABLE 48 China Wearable Injectors Market by End User, 2018 - 2021, USD Million
  • TABLE 49 China Wearable Injectors Market by End User, 2022 - 2028, USD Million
  • TABLE 50 China Wearable Injectors Market by Type, 2018 - 2021, USD Million
  • TABLE 51 China Wearable Injectors Market by Type, 2022 - 2028, USD Million
  • TABLE 52 China Wearable Injectors Market by Technology, 2018 - 2021, USD Million
  • TABLE 53 China Wearable Injectors Market by Technology, 2022 - 2028, USD Million
  • TABLE 54 Japan Wearable Injectors Market, 2018 - 2021, USD Million
  • TABLE 55 Japan Wearable Injectors Market, 2022 - 2028, USD Million
  • TABLE 56 Japan Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
  • TABLE 57 Japan Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
  • TABLE 58 Japan Wearable Injectors Market by End User, 2018 - 2021, USD Million
  • TABLE 59 Japan Wearable Injectors Market by End User, 2022 - 2028, USD Million
  • TABLE 60 Japan Wearable Injectors Market by Type, 2018 - 2021, USD Million
  • TABLE 61 Japan Wearable Injectors Market by Type, 2022 - 2028, USD Million
  • TABLE 62 Japan Wearable Injectors Market by Technology, 2018 - 2021, USD Million
  • TABLE 63 Japan Wearable Injectors Market by Technology, 2022 - 2028, USD Million
  • TABLE 64 India Wearable Injectors Market, 2018 - 2021, USD Million
  • TABLE 65 India Wearable Injectors Market, 2022 - 2028, USD Million
  • TABLE 66 India Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
  • TABLE 67 India Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
  • TABLE 68 India Wearable Injectors Market by End User, 2018 - 2021, USD Million
  • TABLE 69 India Wearable Injectors Market by End User, 2022 - 2028, USD Million
  • TABLE 70 India Wearable Injectors Market by Type, 2018 - 2021, USD Million
  • TABLE 71 India Wearable Injectors Market by Type, 2022 - 2028, USD Million
  • TABLE 72 India Wearable Injectors Market by Technology, 2018 - 2021, USD Million
  • TABLE 73 India Wearable Injectors Market by Technology, 2022 - 2028, USD Million
  • TABLE 74 South Korea Wearable Injectors Market, 2018 - 2021, USD Million
  • TABLE 75 South Korea Wearable Injectors Market, 2022 - 2028, USD Million
  • TABLE 76 South Korea Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
  • TABLE 77 South Korea Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
  • TABLE 78 South Korea Wearable Injectors Market by End User, 2018 - 2021, USD Million
  • TABLE 79 South Korea Wearable Injectors Market by End User, 2022 - 2028, USD Million
  • TABLE 80 South Korea Wearable Injectors Market by Type, 2018 - 2021, USD Million
  • TABLE 81 South Korea Wearable Injectors Market by Type, 2022 - 2028, USD Million
  • TABLE 82 South Korea Wearable Injectors Market by Technology, 2018 - 2021, USD Million
  • TABLE 83 South Korea Wearable Injectors Market by Technology, 2022 - 2028, USD Million
  • TABLE 84 Singapore Wearable Injectors Market, 2018 - 2021, USD Million
  • TABLE 85 Singapore Wearable Injectors Market, 2022 - 2028, USD Million
  • TABLE 86 Singapore Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
  • TABLE 87 Singapore Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
  • TABLE 88 Singapore Wearable Injectors Market by End User, 2018 - 2021, USD Million
  • TABLE 89 Singapore Wearable Injectors Market by End User, 2022 - 2028, USD Million
  • TABLE 90 Singapore Wearable Injectors Market by Type, 2018 - 2021, USD Million
  • TABLE 91 Singapore Wearable Injectors Market by Type, 2022 - 2028, USD Million
  • TABLE 92 Singapore Wearable Injectors Market by Technology, 2018 - 2021, USD Million
  • TABLE 93 Singapore Wearable Injectors Market by Technology, 2022 - 2028, USD Million
  • TABLE 94 Malaysia Wearable Injectors Market, 2018 - 2021, USD Million
  • TABLE 95 Malaysia Wearable Injectors Market, 2022 - 2028, USD Million
  • TABLE 96 Malaysia Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
  • TABLE 97 Malaysia Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
  • TABLE 98 Malaysia Wearable Injectors Market by End User, 2018 - 2021, USD Million
  • TABLE 99 Malaysia Wearable Injectors Market by End User, 2022 - 2028, USD Million
  • TABLE 100 Malaysia Wearable Injectors Market by Type, 2018 - 2021, USD Million
  • TABLE 101 Malaysia Wearable Injectors Market by Type, 2022 - 2028, USD Million
  • TABLE 102 Malaysia Wearable Injectors Market by Technology, 2018 - 2021, USD Million
  • TABLE 103 Malaysia Wearable Injectors Market by Technology, 2022 - 2028, USD Million
  • TABLE 104 Rest of Asia Pacific Wearable Injectors Market, 2018 - 2021, USD Million
  • TABLE 105 Rest of Asia Pacific Wearable Injectors Market, 2022 - 2028, USD Million
  • TABLE 106 Rest of Asia Pacific Wearable Injectors Market by Therapy, 2018 - 2021, USD Million
  • TABLE 107 Rest of Asia Pacific Wearable Injectors Market by Therapy, 2022 - 2028, USD Million
  • TABLE 108 Rest of Asia Pacific Wearable Injectors Market by End User, 2018 - 2021, USD Million
  • TABLE 109 Rest of Asia Pacific Wearable Injectors Market by End User, 2022 - 2028, USD Million
  • TABLE 110 Rest of Asia Pacific Wearable Injectors Market by Type, 2018 - 2021, USD Million
  • TABLE 111 Rest of Asia Pacific Wearable Injectors Market by Type, 2022 - 2028, USD Million
  • TABLE 112 Rest of Asia Pacific Wearable Injectors Market by Technology, 2018 - 2021, USD Million
  • TABLE 113 Rest of Asia Pacific Wearable Injectors Market by Technology, 2022 - 2028, USD Million
  • TABLE 114 Key Information - Insulet corporation
  • TABLE 115 Key Information - United Therapeutics Corporation
  • TABLE 116 Key Information - ATS Automation Tooling Systems, Inc.
  • TABLE 117 Key Information - Ypsomed AG
  • TABLE 118 Key Information - Amgen, Inc.
  • TABLE 119 Key information - West Pharmaceutical Services, Inc.
  • TABLE 120 Key Information - Zealand Pharma A/S
  • TABLE 121 Key Information - Medtronic PLC
  • TABLE 122 Key Information - CeQur SA
  • TABLE 123 Key Information - Subcuject ApS

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018,Apr - 2022, Apr) Leading Players
  • FIG 5 Recent strategies and developments: United Therapeutics Corporation
  • FIG 6 Recent strategies and developments: Ypsomed AG
  • FIG 7 Recent Strategies and Developments: West Pharmaceutical Services, Inc.
  • FIG 8 Recent strategies and developments: Medtronic PLC
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!